Safety and Toxicity Study of IMM27M in Patients With Advanced Solid Tumor
Clinical trial NCT05235438 · UNKNOWN
Trial details
- NCT number
- NCT05235438
- Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2023-08-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.